PNU-282,987
PNU-282,987 is a drug that acts as a potent and selective agonist for the α7 subtype of neural nicotinic acetylcholine receptors. In animal studies, it shows nootropic effects, and derivatives may be useful in the treatment of schizophrenia, although PNU-282,987 is not suitable for use in humans because of excessive inhibition of the hERG antitarget. PNU-282987 has been shown to initiate signaling that leads to adult neurogeneis in mammals.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
PNU-282,987
PNU-282,987 is a drug that acts as a potent and selective agonist for the α7 subtype of neural nicotinic acetylcholine receptors. In animal studies, it shows nootropic effects, and derivatives may be useful in the treatment of schizophrenia, although PNU-282,987 is not suitable for use in humans because of excessive inhibition of the hERG antitarget. PNU-282987 has been shown to initiate signaling that leads to adult neurogeneis in mammals.
has abstract
PNU-282,987 is a drug that act ...... adult neurogeneis in mammals.
@en
CAS number
123464-89-1
ChEMBL
FDA UNII code
810P1694K2
PubChem
Wikipage page ID
24,509,866
page length (characters) of wiki page
Wikipage revision ID
991,736,002
Link from a Wikipage to another Wikipage
CAS number
ChEMBL
ChemSpiderID
IUPAC name
N-[-1'-azabicyclo[2.2.2]oct-3'-yl]-4-chlorobenzamide
@en
molecular weight
PubChem
SMILES
C1CN2CCC1[C@H]NCC3=CC=CCl
@en
StdInChIKey
WECKJONDRAUFDD-ZDUSSCGKSA-N
@en
verifiedrevid
403,684,050
wikiPageUsesTemplate
hypernym
comment
PNU-282,987 is a drug that act ...... adult neurogeneis in mammals.
@en
label
PNU-282,987
@en